Deciphering inhibitory activity of marine algae Ecklonia cava phlorotannins against SARS CoV-2 main protease: A coupled in-silico docking and molecular dynamics simulation study

被引:3
作者
Chakraborty, Ayon [1 ]
Ghosh, Rajesh [2 ]
Barik, Subhashree [2 ]
Mohapatra, Saswati Soumya [2 ]
Biswas, Ashis [2 ]
Chowdhuri, Snehasis [2 ]
机构
[1] Chandigarh Univ, Univ Ctr Res & Dev, Univ Inst Technol, Mohali, India
[2] Indian Inst Technol Bhubaneswar, Sch Basic Sci, Bhubaneswar, India
关键词
COVID-19; SARS CoV-2 main protease; Docking; Molecular dynamics simulation; Marine algae; Ecklonia cava phlorotannins; ANTI-HIV-1; ACTIVITY; MUTATIONS V32I; HIV-1; PROTEASE; CORONAVIRUS; SARS-COV-2; DESIGN; IDENTIFICATION; PROTEINASE; RESISTANCE; MECHANISM;
D O I
10.1016/j.gene.2024.148620
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The onset of COVID-19 due to the SARS CoV-2 virus has spurred an urgent need for potent therapeutics and vaccines to combat this global pandemic. The main protease (Mpro) of the virus, crucial in its replication, has become a focal point in developing anti-COVID-19 drugs. The cysteine protease Mpro in SARS CoV-2 bears a significant resemblance to the same protease found in SARS CoV-1. Previous research highlighted phlorotannins derived from Ecklonia cava, an edible marine algae, as inhibitors of SARS CoV-1 Mpro activity. However, it remains unclear whether these marine-derived phlorotannins also exert a similar inhibitory effect on SARS CoV-2 Mpro. To unravel this, our study utilized diverse in-silico methodologies. We explored the pharmacological potential of various phlorotannins (phloroglucinol, triphloretol-A, eckol, 2-phloroeckol, 7-phloroeckol, fucodiphloroethol G, dieckol, and phlorofucofuroeckol-A) and assessed their binding efficacies alongside established Mpro inhibitors (N3 and lopinavir) through molecular docking studies. Among these compounds, five phlorotannins (eckol, 2-phloroeckol, 7-phloroeckol, dieckol, and phlorofucofuroeckol-A) exhibited potent binding affinities comparable to or surpassing N3 and lopinavir, interacting especially with the catalytic residues His41 and Cys145 of Mpro. Moreover, molecular dynamics simulations revealed that these five Mpro-phlorotannin complexes displayed enhanced stability and maintained comparable or slightly reduced compactness. They exhibited reduced conformational changes and increased expansion relative to the Mpro-N3 and/or Mprolopinavir complex. Our MM-GBSA analysis further supported these findings. Overall, our investigation highlights the potential of these five phlorotannins in inhibiting the proteolytic function of SARS CoV-2 Mpro, offering promise for anti-COVID-19 drug development.
引用
收藏
页数:14
相关论文
共 80 条
  • [1] Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations
    Aanouz, I.
    Belhassan, A.
    El-Khatabi, K.
    Lakhlifi, T.
    El-Idrissi, M.
    Bouachrine, M.
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (08) : 2971 - 2979
  • [2] Gromacs: High performance molecular simulations through multi-level parallelism from laptops to supercomputers
    Abraham, Mark James
    Murtola, Teemu
    Schulz, Roland
    Páll, Szilárd
    Smith, Jeremy C.
    Hess, Berk
    Lindah, Erik
    [J]. SoftwareX, 2015, 1-2 : 19 - 25
  • [3] Inhibition of HIV-1 reverse transcriptase and protease by phlorotannins from the brown alga Ecklonia cava
    Ahn, MJ
    Yoon, KD
    Min, SY
    Lee, JS
    Kim, JH
    Kim, TG
    Kim, SH
    Kim, NG
    Huh, H
    Kim, J
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (04) : 544 - 547
  • [4] Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
    Anand, K
    Ziebuhr, J
    Wadhwani, P
    Mesters, JR
    Hilgenfeld, R
    [J]. SCIENCE, 2003, 300 (5626) : 1763 - 1767
  • [5] Anti-HIV-1 activity of phloroglucinol derivative, 6,6′-bieckol, from Ecklonia cava
    Artan, Murat
    Li, Yong
    Karadeniz, Fatih
    Lee, Sang-Hoon
    Kim, Moon-Moo
    Kim, Se-Kwon
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (17) : 7921 - 7926
  • [6] Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target
    Arun, K. G.
    Sharanya, C. S.
    Abhithaj, J.
    Francis, Dileep
    Sadasivan, C.
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (13) : 4647 - 4658
  • [7] Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model
    Beck, Bo Ram
    Shin, Bonggun
    Choi, Yoonjung
    Park, Sungsoo
    Kang, Keunsoo
    [J]. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2020, 18 : 784 - 790
  • [8] MOLECULAR-DYNAMICS WITH COUPLING TO AN EXTERNAL BATH
    BERENDSEN, HJC
    POSTMA, JPM
    VANGUNSTEREN, WF
    DINOLA, A
    HAAK, JR
    [J]. JOURNAL OF CHEMICAL PHYSICS, 1984, 81 (08) : 3684 - 3690
  • [9] Bhardwaj VK, 2020, J BIOMOL STRUCT DYN, V39, P3449, DOI DOI 10.1080/07391102.2020.1766572
  • [10] A computational prediction of SARS-CoV-2 structural protein inhibitors fromAzadirachta indica(Neem)
    Borkotoky, Subhomoi
    Banerjee, Manidipa
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (11) : 4111 - 4121